Cell Surface Protein May Offer Big Target in Treating High-Risk Childhood Cancers


Newswise imageOncology researchers studying high-risk children’s cancers have identified a protein that offers a likely target for immunotherapy–harnessing the immune system in medical treatments. In cell cultures and animal models, a potent drug attached to an antibody selectively zeroes in on cancer cells without harming healthy cells.